Alnylam Pharmaceuticals, Inc. (ALNY)
236.06
-0.16
(-0.07%)
USD |
NASDAQ |
Aug 24, 16:00
237.08
+1.02
(+0.43%)
After-Hours: 20:00
Alnylam Pharmaceuticals Shareholders Equity (Quarterly) : 1.354B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.354B |
| March 31, 2026 | 1.075B |
| December 31, 2025 | 789.18M |
| September 30, 2025 | 233.89M |
| June 30, 2025 | 250.59M |
| March 31, 2025 | 115.44M |
| December 31, 2024 | 67.09M |
| September 30, 2024 | 32.35M |
| June 30, 2024 | -3.067M |
| March 31, 2024 | -219.27M |
| December 31, 2023 | -220.64M |
| September 30, 2023 | -165.87M |
| June 30, 2023 | -408.13M |
| March 31, 2023 | -259.24M |
| December 31, 2022 | -158.22M |
| September 30, 2022 | -67.64M |
| June 30, 2022 | 176.04M |
| March 31, 2022 | 401.17M |
| December 31, 2021 | 588.20M |
| September 30, 2021 | 755.89M |
| June 30, 2021 | 853.36M |
| March 31, 2021 | 926.19M |
| December 31, 2020 | 1.016B |
| September 30, 2020 | 1.215B |
| June 30, 2020 | 1.400B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.350B |
| December 31, 2019 | 1.439B |
| September 30, 2019 | 1.607B |
| June 30, 2019 | 1.757B |
| March 31, 2019 | 1.547B |
| December 31, 2018 | 1.302B |
| September 30, 2018 | 1.478B |
| June 30, 2018 | 1.621B |
| March 31, 2018 | 1.755B |
| December 31, 2017 | 1.766B |
| September 30, 2017 | 1.059B |
| June 30, 2017 | 1.123B |
| March 31, 2017 | 830.90M |
| December 31, 2016 | 920.22M |
| September 30, 2016 | 1.015B |
| June 30, 2016 | 1.098B |
| March 31, 2016 | 1.189B |
| December 31, 2015 | 1.265B |
| September 30, 2015 | 1.322B |
| June 30, 2015 | 1.409B |
| March 31, 2015 | 1.497B |
| December 31, 2014 | 936.27M |
| September 30, 2014 | 904.48M |
| June 30, 2014 | 942.27M |
| March 31, 2014 | 954.97M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 439.74M |
| Regeneron Pharmaceuticals, Inc. | 31.71B |
| Vertex Pharmaceuticals, Inc. | 20.25B |
| BridgeBio Pharma, Inc. | -2.515B |
| Pfizer Inc. | 85.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.559B |
| Total Liabilities (Quarterly) | 4.205B |
| Debt to Equity Ratio | 2.206 |
| Current Ratio | 3.055 |
| Net Debt Paydown Yield | -0.13% |